Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc
Journal website https://www.cardiologyres.org

Original Article

Volume 4, Number 6, December 2013, pages 192-198


One-Year Outcomes After Everolimus-Eluting Stents Implantation in Ostial Lesions of Left Anterior Descending Coronary Arteries

Figure

Figure 1.
Figure 1. Cumulative analysis of event-free survival was expressed by Kaplan-Meier survival curve. 1: Patients with LM-LAD stenting (n: 6, 13.3%); 2: Patients with focal ostial stenting (n: 39, 86.6%).

Tables

Table 1. Baseline Characteristics of the 45 Patients
 
CharacteristicsMean ± SD or n (%)
Age57.44 ± 11.63
Male35 (77.7)
Risk factors
  Systemic hypertension15 (33.3)
  Diabetes20 (44.4)
  Total serum cholesterol ≥ 20016 (35.5)
  Current smoker17 (37.7)
  Family history6 (13.3)
Unstable angina22 (48.8)
ST elevation myocardial infarction > 2 days16 (35.5)
Non-Q wave myocardial infarction2 (4.4)
Left ventricular ejection fraction45.5 ± 12.9
Diseased vessels, n
  126 (57.7)
  214 (31.1)
  35 (11.1)
Coronary lesion characteristics
  Discrete < 10 mm16 (35.5)
  Tubular 10 - 20 mm23 (51.1)
  Diffuse > 20 mm7 (15.5)
Preintervention TIMI grade
  I5 (11.1)
  II10 (22.2)
  III30 (66.6)
Thrombus1 (2.2)

 

Table 2. Angiographic Characteristics of the 45 Lesions
 
CharacteristicsMean ± SD
Distal reference vessel diameter (mm)3.08 ± 0.53
Balloon to artery ratio1.1 ± 0.3
Maximal balloon inflation pressure (atm)15.11 ± 2.47
Percent diameter stenosis (%)81.5 ± 14.5
Angiographic restenosis (%)4.4
No distal LM lesion n (%)39 (86.6)
Distal LM lesion n (%)6 (13.3)
Lesion length (mm)19.06 ± 8.05

 

Table 3. Clinical Outcomes in the Hospital and During Follow-Up (12 Months)
 
Clinical eventsN (%)
MACE2 (4.4)
In-hospital
Procedure success(100)
Death0 (0)
Stent thrombosis0 (0)
Emergency CABG0 (0)
During follow-up
Non-related myocardial infarction2 (4.4)
Death0 (0)
Target lesion revascularization2 (4.4)
CABG1 (2.2)
Target vessel revascularization0 (0)
Angiographic F/U by symptom of angina pectoris or positive non-invasive test16 (35.5)
Patients with only clinical F/U29 (64.4)